Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jianpi Fuzheng Fang is a Traditional Chinese Medicine (TCM) herbal formula developed for the treatment and prevention of ischemic stroke, particularly in patients exhibiting Spleen Deficiency Syndrome. The formula is designed to strengthen the spleen and support the body's vital energy (Qi), adhering to the TCM principle of "Jianpi Fuzheng" (strengthening the spleen and supporting the correct). In clinical trials conducted by Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, it is evaluated as an adjunctive therapy alongside standard Western medicine secondary prevention programs to improve neurological recovery outcomes and prevent stroke recurrence. The formula is typically administered orally as a tea or decoction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jianpi Fuzheng Fang.